Cohort Company News - MedTech Innovator

Conversations with Medtech Pioneers: MedTech Innovator’s 2020 Grand Prize Winner, Rhaeos

DateDec 08 2020

At Advamed’s Medtech Conference, the top 5 finalists pitched with the Grand Prize awarded to Rhaeos CEO, Anna Lisa Somera. Rhaeos has a novel wireless, wearable sensor for the monitoring of shunts in patients with Hydrocephalus.

Safety and Efficacy of Intermittent Colonic Exoperistalsis Device to Treat Chronic Constipation: A Prospective Multicentric Clinical Trial, featuring MOWOOT

DateDec 01 2020

MOWOOT automatically provides intermittent colonic exo-peristalsis (ICE) treatment like that in manual massage.

This Startup Is Changing Cancer Detection Around the World (featuring X-ZELL)

DateDec 01 2020

X-ZELL is developing an accurate, affordable, and globally scalable early cancer detection from 10mL blood samples, which is unprecedented.

Vectorious’ In-Heart Microcomputer Wins FDA Breakthrough Nod

DateNov 30 2020

The V-LAP system is the first digital, wireless, battery-free device that can communicate from deep within the body using high-resolution waveform morphology, according to the Tel Aviv-based startup.

First Use of nView’s Novel 3D Imaging Technology in Pediatric Spine Surgery

DateNov 24 2020

The innovation, insta-3D™ imaging from company nView medical, is designed to make 3D images available in the operating room quickly and safely. The 3D images provide surgeons with better visualization, allowing them to continue improving patient care and outcomes.

GT Medical Technologies Announces $16 Million Financing to Expand Availability of Targeted Therapy for Patients with Recurrent Brain Tumors

DateNov 23 2020

GT Medical Technologies, Inc., a company dedicated to improving the lives of patients with brain tumors, today announced it has raised $16 million in a Series B financing led by MVM Partners with participation from existing investors MedTech Venture Partners and BlueStone Venture Partners.

New Diabetes ‘CGKM’ Sensor Will Monitor Both Glucose and Ketones (featuring PercuSense)

DateNov 22 2020

Digital health startup PercuSense in Southern California — which has former Medtronic Diabetes engineering talent at its helm — is working on this next-generation tech for diabetes, a combined continuous glucose monitor (CGM) that also keeps tabs on ketones.

Explorer Surgical Launches Advanced Video for Remote Surgery

DateNov 22 2020

ExplORer Surgical, a Chicago-based startup that's developed an interactive platform for surgeons, has launched a new suite of advanced audio and video capabilities to make remote support easier in the operating room (OR).

Subtle Medical Raises $12.2 Million in Series A Funding to Expand Its AI Imaging Solutions

DateNov 19 2020

Subtle will use the funds to grow their product portfolio and support the global demand to make medical imaging faster and safer for all.

Medable raises $91M for Its Clinical Trial Management Software

DateNov 19 2020

The clinical trial management software developer Medable has raised $91 million in a new round of financing as life sciences companies struggle with how to conduct the necessary validation studies of new drugs and devices in a pandemically challenged environment.

Allotrope Medical Announces FDA Clearance of StimSite™

DateNov 17 2020

StimSite provides ob/gyns, general and colorectal surgeons the new ability to use their existing surgical instruments to help locate and identify ureters using electrical stimulation.

X-COR Therapeutics, an Alira Health Ventures Portfolio Company, Closes Initial $2.6M Funding Round.

DateNov 12 2020

Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, congratulates X-COR Therapeutics for closing a $2.6M seed financing to continue developing its novel extracorporeal carbon dioxide removal device toward clinical trials.

CoapTech Awarded $1.6M from NIH for Pediatric Feeding Tube Placement Device

DateNov 12 2020

Grant will support development and clinical evaluation of world’s first ultrasound-based gastrostomy device for pediatric patients.

Nanowear Receives FDA 510(k) Clearance for SimpleSENSE, a Cloth-Based Wearable Remote Diagnostic Monitoring Platform

DateNov 11 2020

Nanowear www.nanowearinc.com, the leading connected-care and remote diagnostic platform, today announced it has received FDA Class II 510(k) clearance for a first-of-its-kind cloth-based diagnostic platform, SimpleSENSE.

UCSF Rosenman Institute Announces Companies Chosen for “ADAPT” Program (featuring Vynca)

DateNov 10 2020

The UCSF Rosenman Institute announced today the startups selected in “UCSF Rosenman ADAPT,” a competitive global program for startup companies developing solutions to increase healthcare efficiency. Bold, ConsejoSano, EMME, GroupWell, Oshi, Vynca, and Woebot were selected for their innovative approaches and market promise.

SepTec Is One of the 6 Winners of the Eit Health UK-Ireland #Headstart €10,000 Top up Pitch

DateNov 06 2020

SepTec Ltd Is immensely proud to be one of the 6 winners of the EIT HEALTH UK-IRELAND #Headstart €10,000 top up pitch!

Avisi Technologies: $1M NSF Grant

DateNov 03 2020

The funding will help prepare the team for clinical trials, which they plan to begin in 2021.

PercuSense Announces Project with the University of Melbourne funded by The Helmsley Charitable Trust to Develop a Single Sensor Continuous Glucose and Ketone Monitor

DateNov 02 2020

PercuSense, an intelligent biosensor and digital health company, announced it has been awarded a $2.5 million program-related investment in the form of a loan from The Leona M. and Harry B. Helmsley Charitable Trust. PercuSense will use the funding to continue development on its novel continuous monitoring system that measures both glucose and ketones on a single minimally invasive probe.

Robotic Catheterization for Mitral Valve Repair: Interview with Mark Barrish, CEO of Moray Medical

DateOct 28 2020

Moray Medical, a company based in Mountain View, California, has developed a robotic catheter and associated technology, including augmented reality and a 3D digital interface, designed to make the job easier. In fact, the company claims that using its technology to deliver cardiac therapies can be as simple as moving a cursor on a computer screen.

Venari Medical Secures $5.3M Investment to Advance the Minimally Invasive Treatment of Chronic Venous Disease

DateOct 28 2020

Venari Medical, an innovative medical device company based in Galway (Ireland), recently raised $5.3 million (€4.5 million) in seed equity funding to accelerate the development of its ground-breaking BioVena™ device for the treatment of chronic venous disease.